Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,570 | 4,678 | 7,109 | 8,640 | 9,877 |
| Other current assets | 954 | 1,006 | 125 | 106 | 120 |
| TOTAL | $2,524 | $5,684 | $7,234 | $8,746 | $9,996 |
| Non-Current Assets | |||||
| PPE Net | 1,386 | 1,391 | 1,029 | 953 | 930 |
| Other Non-Current Assets | 27 | 0 | 0 | 0 | 0 |
| TOTAL | $1,413 | $1,391 | $1,029 | $953 | $930 |
| Total Assets | $3,937 | $7,074 | $8,263 | $9,699 | $10,926 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 571 | 1,697 | 491 | 445 | 511 |
| Accrued Expenses | 337 | 351 | 577 | 286 | 244 |
| TOTAL | $909 | $2,048 | $1,068 | $731 | $755 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $909 | $2,048 | $1,068 | $731 | $755 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70 | 70 | 70 | 70 | 70 |
| Common Shares | 231 | 231 | 58 | 231 | 231 |
| Retained earnings | -105,220 | -103,055 | -100,681 | -98,804 | -97,507 |
| TOTAL | $3,028 | $5,027 | $7,195 | $8,968 | $10,172 |
| Total Liabilities And Equity | $3,937 | $7,074 | $8,263 | $9,699 | $10,926 |